Galectin-7 as a biomarker for aggressiveness and poor prognosis in thymic epithelial tumors
Galectin-7 is a potential biomarker for aggressive TETs, with expression levels associated with features of poor prognosis. These findings provide insight into TET biology and support further exploration of Galectin-7 in tumor stratification and therapeutic research.
Authors
- Kunping Li (ORCID: https://orcid.org/0000-0003-2364-8988)
- Qiangling Sun
- Yilv Lv
- Wentao Fang (ORCID: https://orcid.org/0000-0002-6517-9975)
- Ning Xu (ORCID: https://orcid.org/0000-0001-7909-7025)
- Xuefei Zhang (ORCID: https://orcid.org/0000-0001-9187-2004)
- Teng Mao
- Zhitao Gu (ORCID: https://orcid.org/0000-0001-8064-3214)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
- Shanghai East Hospital (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1016/j.tranon.2025.102612
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00